Table 5.
Individual Outcome Events
| Outcome | N (%)a |
|---|---|
| Total mortality | 36 (5.7) |
| Cardiac mortality | 8 (1.3) |
| Cardiovascular mortality | 11 (1.7) |
| MI (nonfatal) | 10 (1.6) |
| STEMI | 4 (0.63) |
| Non‐STEMI | 6 (0.95) |
| Unstable angina | 7 (1.1) |
| New‐onset angina requiring revascularization | 20 (3.2) |
| CVA | 20 (3.2) |
| TIA | 9 (1.4) |
| Revascularization | 45 (7.1) |
| CABG | 13 (2.1) |
| PCI | 32 (5.1) |
| Major amputation | 2 (0.31) |
| Minor amputations | 2 (0.31) |
| Intraocular therapy for retinopathy | 52 (8.3) |
| Acute intraocular vascular event | 5 (0.79) |
| Diabetic ulcer | 13 (2.1) |
| Primary CHD outcome eventb | 41 (6.5) |
| Cardiovascular death or MI | 21 (3.3) |
| Noncoronary vascular eventb | 96 (15.2) |
| Macrovascular eventb | 67 (10.6) |
| Microvascular eventb | 59 (9.4) |
CABG indicates coronary artery bypass surgery; CHD, coronary heart disease; CVA, cerebrovascular accident; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST elevation myocardial infarction; TIA, transient ischemic attack.
a
All fatal events are listed, whereas for other components of the primary CHD outcome (MI, unstable angina, and new chest pain requiring revascularization) the first event (that included in the primary time to event outcome) is listed.